Jian Yanlin, Zhou Tianyang, Guo Chendong, Gao Yibo, Yao Chen, Wang Zixi, Jiang Xuehan, Wang Ke, Ma Jian, Gao Yang, Fan Yizeng, Liu Jing, Ma Bohan, Li Lei
Department of Urology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Acta Pharm Sin B. 2025 May;15(5):2625-2639. doi: 10.1016/j.apsb.2025.03.049. Epub 2025 Apr 4.
Arginine methylation is a critical post-translational modification that plays multifaceted biological functions. However, the manipulation of protein arginine methylation largely depends on genetic or pharmaceutic inhibition of the regulatory enzymes, protein arginine methyltransferases (PRMTs), or non-methylation substitution of corresponding arginine residue to lysine or alanine of protein of interest (POI), which inevitably affects other substrates, or disrupts the structure of POI. Thus, it urges an approach to specifically modulate the arginine methylation of a POI under physiological conditions. To this end, we report the discovery of a methylation tagging system (MeTAG), that enables targeted modification of protein arginine methylation. Through bridging the methyltransferase PRMT5 proximity to a POI, MeTAG facilitates the arginine methylation of POIs, including known arginine methylated proteins, androgen receptor (AR) and protein kinase B (AKT), as well as a neo-substrate E1A binding protein (p300), in a reversible and PRMT5-dependent manner. Moreover, MeTAG can regulate downstream signaling in a methylation dependent manner, leading to downregulation of mRNA level and activation of AKT. Therefore, MeTAG represents a feasible approach to modulate protein methylation and thereby perturbs protein function in biological and therapeutic contexts.
精氨酸甲基化是一种关键的翻译后修饰,具有多方面的生物学功能。然而,对蛋白质精氨酸甲基化的调控很大程度上依赖于对调节酶——蛋白质精氨酸甲基转移酶(PRMTs)的基因或药物抑制,或者将目标蛋白(POI)相应的精氨酸残基非甲基化替换为赖氨酸或丙氨酸,这不可避免地会影响其他底物,或破坏POI的结构。因此,迫切需要一种在生理条件下特异性调节POI精氨酸甲基化的方法。为此,我们报道了一种甲基化标记系统(MeTAG)的发现,该系统能够对蛋白质精氨酸甲基化进行靶向修饰。通过将甲基转移酶PRMT5与POI拉近,MeTAG以可逆且依赖PRMT5的方式促进POI的精氨酸甲基化,这些POI包括已知的精氨酸甲基化蛋白、雄激素受体(AR)和蛋白激酶B(AKT),以及一种新底物E1A结合蛋白(p300)。此外,MeTAG能够以甲基化依赖的方式调节下游信号传导,导致mRNA水平下调和AKT激活。因此,MeTAG是一种在生物学和治疗背景下调节蛋白质甲基化从而干扰蛋白质功能的可行方法。